Q4 2023 Holdings
Filed 2024-02-14 | 7 holdings | $404.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Mimedx Group, Inc.(MDXG) | COM | 602496101 | $247.3M | 28,195,249 | 61.2% |
| Bioventus(BVS) | COM CL A | 09075A108 | $68.6M | 13,021,324 | 17.0% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $54.0M | 2,337,786 | 13.4% |
| Tela BIO, Inc.(TELA) | COM | 872381108 | $27.2M | 4,110,709 | 6.7% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $4.0M | 457,085 | 1.0% |
| Medicinova Inc(MNOV) | COM NEW | 58468P206 | $1.7M | 1,105,941 | 0.4% |
| Venus Concept, Inc. | COM | 92332W105 | $1.3M | 1,089,190 | 0.3% |